Instead, PRAL (P53 regulation-association long non-coding ribonucleic acid), downregulated in HCC, facilitates the interaction of HSP90 and p53, inhibiting MDM2-dependent p53 ubiquitination and resulting in enhanced p53 stability [93]. The gene discussed is TP53; the disease is hepatocellular carcinoma.